300 episodes

The most important stories about money, business and power. Hosted by Kate Linebaugh and Ryan Knutson, with Jessica Mendoza. The Journal is a co-production of Spotify and The Wall Street Journal.

Get show merch here: https://wsjshop.com/collections/clothing

The Journal‪.‬ The Wall Street Journal

    • News
    • 4.2 • 4.9K Ratings

The most important stories about money, business and power. Hosted by Kate Linebaugh and Ryan Knutson, with Jessica Mendoza. The Journal is a co-production of Spotify and The Wall Street Journal.

Get show merch here: https://wsjshop.com/collections/clothing

    The Hidden Life of Google’s Secret Weapon

    The Hidden Life of Google’s Secret Weapon

    Joshua Wright was a star in the world of antitrust, from his time at the Federal Trade Commission to his work with some of the biggest tech companies. He was well respected and powerful until accusations of sexual misconduct came to light. WSJ’s Brody Mullins talks us through his reporting on Wright’s downfall.



    Further Reading:

    - The Hidden Life of Google’s Secret Weapon 

    - For Years, an Esteemed Law Professor Seduced Students. Was He Too Important to Fire? 

    - Hubris, Revenge and a Breakup Brought Down Big Tech’s Proudest Ally 



    Further Listening:

    - Elon Musk’s Unusual Relationships With Women at SpaceX 

    - Lewd Photos, Booze and Bullying: Inside the FDIC’s Toxic Culture 





    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 24 min
    Elon Musk’s Unusual Relationships With Women at SpaceX

    Elon Musk’s Unusual Relationships With Women at SpaceX

    The billionaire founder showed several female employees at SpaceX an unusual amount of attention or pursued them. WSJ's Joseph Palazzolo describes the revelations.



    Further Reading:

    -Elon Musk’s Boundary-Blurring Relationships With Women at SpaceX 



    Further Listening:

    -Money, Drugs, Elon Musk and Tesla's Board 

    -Elon Musk's 'Demon Mode' 

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 24 min
    New York’s U-Turn on a Plan to Reduce Traffic

    New York’s U-Turn on a Plan to Reduce Traffic

    The nation’s first congestion-pricing plan was set to take effect at the end of June. But last week, New York Gov. Kathy Hochul called to indefinitely delay the program. WSJ's Jimmy Vielkind unpacks the surprising move and explores why Hochul made the 11th hour change.



    Further Reading:

    -New York Gov. Kathy Hochul Abruptly Halts Manhattan Congestion Pricing 



    Further Listening:

    -NYC’s Food Delivery Workers Fight for a Minimum Wage 

    -New York City's 'De Facto Ban' on Airbnb 

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 19 min
    Shein: Fast Fashion, Slow IPO

    Shein: Fast Fashion, Slow IPO

    The fast-fashion giant hoped to have a splashy U.S. public offering this year. WSJ's Shen Lu explains how the divide between Beijing and Washington got in the way.



    Further Reading:

    - Shein Promised to Have a Big U.S. IPO. Its China Roots Got in the Way. 

    - Fast-Fashion Giant Shein Files to Go Public 



    Further Listening:

    - Shein Took Over Fast Fashion. Then Came the Backlash. 

    - The Mysterious CEO Leading Shein to an IPO 



    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 19 min
    Trillion Dollar Shot, Episode 4: The Disruptors

    Trillion Dollar Shot, Episode 4: The Disruptors

    The rising popularity of GLP-1 drugs could cause all kinds of ripple effects.

    According to one estimate, 9% of the U.S. population could be on Ozempic or similar medications by 2030. Meanwhile, drugmakers are already developing the next generation of weight-loss drugs and researchers are studying the possible health benefits beyond weight loss and diabetes, including addiction.

    In the final episode of our series we ask: What could all this development mean for businesses, from the food sector to airlines? And who wins and who loses in the post-Ozempic economy?

    Guests include: David Ricks, CEO of Eli Lilly; and Mehdi Farokhnia, an addiction researcher at the National Institutes of Health.

    Listen to Episodes 1, 2 and 3 of “Trillion Dollar Shot” here. 
    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 43 min
    ‘It Came out of Nowhere’: The Rise of Dr Pepper

    ‘It Came out of Nowhere’: The Rise of Dr Pepper

    There is a new contender in the cola wars, and it isn’t a cola. It’s Dr Pepper. WSJ’s Jennifer Maloney unpacks how after decades as a distant competitor, Dr Pepper has climbed the soda ranks with help from hefty marketing, novel flavors and TikTok videos.



    Further Reading:

    - Dr Pepper Ties Pepsi as America’s No. 2 Soda



    Further Listening:

    - The Agony and Ecstasy of Tab 



    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 21 min

Customer Reviews

4.2 out of 5
4.9K Ratings

4.9K Ratings

Not_a_froggo👍👍👍 ,

I love this pod :)

This is one of my fav pods I like to listen to it in the background when I draw . I want to learn more about the economy and how to prevent inflation and other economical issues :D

Also I do saw the other reviews. I wasn’t paying too much attention but based on others’ opinions, perhaps you could address this?

Indyeche ,

Good information

Thank for your work
Easy to understand and quick

NYC698 ,

Ozempic advertising?

I listed to all four of the “shot” episodes and was disappointed in the lack of serious journalism and clear language. For example, in the final episode, there was a significant discussion about the potential ancillary benefits of the weight loss drug, e.g., heart, etc. But from my readings, it’s not the drugs, but the weight loss itself, that’s causing these benefits. The whole thing just felt like n Ozempic/et al ad without hard questions.

Top Podcasts In News

The Daily
The New York Times
Candace
Candace Owens
The Tucker Carlson Show
Tucker Carlson Network
Up First
NPR
Pod Save America
Crooked Media
The Ben Shapiro Show
The Daily Wire

You Might Also Like

WSJ What’s News
The Wall Street Journal
WSJ Your Money Briefing
The Wall Street Journal
WSJ Tech News Briefing
The Wall Street Journal
WSJ’s The Future of Everything
The Wall Street Journal
WSJ Minute Briefing
The Wall Street Journal
The Daily
The New York Times

More by The Wall Street Journal

WSJ What’s News
The Wall Street Journal
WSJ Your Money Briefing
The Wall Street Journal
WSJ Tech News Briefing
The Wall Street Journal
WSJ Opinion: Potomac Watch
Paul Gigot, The Wall Street Journal
WSJ Minute Briefing
The Wall Street Journal
WSJ’s The Future of Everything
The Wall Street Journal